A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
The FDA on Thursday gave the green light to Uplizna in IgG4-related disease, making it the first and only approved treatment ...
With a label expansion for Uplizna pushing the drug into an untouched rare disease market, Amgen is getting its money’s worth ...
The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at ...
The following is a summary of “Evaluating the therapeutic potential of tofacitinib in Sjögren’s disease: a comprehensive ...
Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other ...
Advanced HIV Disease is when a person living with HIV has a CD4 cell count of below 200 cells. CD4 cells are white blood ...
Ischemic heart disease is a common consequence of coronary artery disease (CAD), which is primarily driven by atherosclerosis, a chronic inflammatory ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
AZoLifeSciences on MSN11d
Immune System Peacekeepers Key to Preventing Autoimmunity During InfectionDuring infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and ...
During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and ...
Aura Biosciences (AURA) announced data from a completed Phase 1 window of opportunity trial of bel-sar in patients with NMIBC. These data were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback